Warning: Creating default object from empty value in /home4/sspccco/public_html/pharmafacts.com/plugins/system/J2top.php on line 78
Competitive Market Intelligence, Drug Development Strategist - PharmaFacts
gototopgototop
If you don't find what you're looking for, please let us know.

Competitive Market Intelligence, Drug Development Strategist

  • 36 years of diverse experiences in biomedicine
  • 4 years as independent consultant advising on commercialization strategy, strategic planning and market analysis in pharmaceutics & emerging technology (biomarkers, imaging and nanotechnology)
  • Clients:  Global Fortune 500 pharmaceutical companies, idea-stage to small biotechnology companies, boutique intellectual-property law firm
  • 1 year as Business Advisor for funding and implementation of product development for idea-stage biotechnology
  • 32 years as researcher and co-principal investigator at leading biomedical and health-science research centers

 

Specific Areas of Expertise

  • Competitive positioning strategy and commercial development strategy for business proposals and investor presentations. 
  • Competitive intelligence for commercialization strategy, strategic planning and market analysis
  • Assessment of technical readiness and commercial feasibility of emerging and competing technologies 
  • Assistance in patent strategy
  • Scientific expertise:  Biochemistry, Cell Biology, Molecular Biology, Immunology
  • Therapeutic areas:  CNS, Ophthalmology, Immunology, Oncology, Metabolism
  • 14 Publications

 

Consulting Engagements

  • Emerging developments and trends in the treatment of glaucoma
  • Emerging developments and trends in the treatment and diagnosis of Alzheimer’s disease
  • Regulatory issues in clinical trials for the treatment of Alzheimer’s disease: use of biomarkers, and clinical trial design
  • Marketing strategy for implementation of nanotechnology for drug delivery as a product line extension
  • Health-care reform in China:  implications for multinational pharmaceutical companies
  • Technical review of patent prosecution history for invalidation opinion
  • Recommendation of marketable business opportunities worthy of patent prosecution for regulated self-assembly of  proteins
  • Gene barcode for microarray analysis – business guidance for market analysis
  • Multiplexed molecular diagnostic tests for detection of infectious diseases – business guidance for market analysis
  • EM-CCD cameras for single molecule spectroscopy and imaging – market advisory
  • Targeted inhibition of cancer stem cells – business guidance on proposal development (business plan and investor pitch) to fund proof-of-concept study for a potentially immunotherapeutic discovery
  • Nanotechnology-enabled lab-on-a chip for rapid detection of micro RNA – secured funding and provided business guidance for product development, including go-to-market exit strategy

 

Professional Positions & Activities

  • Business Advisor, QED Proof-of-Concept Program)                                          University City Science Center
  • Research Assistant Professor/Adjunct Professor                                               Thomas Jefferson University
  • Research Assistant Professor/Adjunct Professor                                               Wistar Institute
  • Research Assistant Professor/Adjunct Professor               University of Pennsylvania School of Medicine
  • Children’s Hospital of Philadelphia                                           Research Assistant Professor/Adjunct Professor